Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Rallybio CFO Jonathan Lieber Transitions To Part Time Role
PUBLIC · RLYBSep 09, 2026•about 2 hours ago
Position
Chief Financial Officer
Company
Rallybio Corporation
Jonathan Lieber
New Haven
Description
On September 8, 2026, Rallybio Corporation announced that Jonathan Lieber will transition to part-time employment status effective September 15, 2026. He will retain his positions as Chief Financial Officer and Principal Financial Officer. Mr
Company Information
Company
Rallybio Corporation
Location
New Haven, Connecticut, United States
About
Rallybio Corporation is a clinical-stage biotechnology company focused on translating scientific advances into transformative therapies for patients suffering from rare diseases. They are developing innovative treatments like RLYB212, aimed at preventing maternal alloimmunization and fetal neonatal alloimmune thrombocytopenia (FNAIT). Their work emphasizes model-informed approaches to enhance safety and dosing during pregnancies. Additionally, they conduct studies to provide contemporary data on alloimmunization frequency in diverse populations.
Don't miss Rallybio Corporation's next move
Get an email the moment Rallybio Corporation changes its leadership, hires an exec, or expands, usually minutes after it happens.
New Haven